- Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis
-
Jang YO, Jun BG, Baik SK, Kim MY, Kwon SO
- KMID: 2164364
- Clin Mol Hepatol.
- 2015 Jun;21(2):141-149.
- doi: 10.3350/cmh.2015.21.2.141
BACKGROUND/AIMS: Therapies involving bone-marrow-derived mesenchymal stem cells (BM-MSCs) have considerable potential in the management of hepatic disease. BM-MSCs have been investigated in regenerative medicine due to their ability to secrete... -
- CITED
-
- Close
- SHARE
-
- Close
